CDIO - Cardio Diagnostics Holdings, Inc.

0.484
-0.036   -7.417%

Share volume: 1,546,127
Last Updated: 04-25-2025
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances: 0.03%

PREVIOUS CLOSE
CHG
CHG%
$0.52
-0.04
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 35%
Dept financing 13%
Liquidity 50%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
5.84%
1 Month
27.44%
3 Months
0.83%
6 Months
55.23%
1 Year
-30.86%
2 Year
-79.14%
Key data
Stock price
$0.48
P/E Ratio 
0.00
DAY RANGE
$0.46 - $0.56
EPS 
-$0.67
52 WEEK RANGE
$0.19 - $1.77
52 WEEK CHANGE
-$30.86
MARKET CAP 
37.083 M
YIELD 
N/A
SHARES OUTSTANDING 
23.942 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
2.95
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,127,572
AVERAGE 30 VOLUME 
$868,970
Company detail
CEO: Meeshanthini Dogan
Region: US
Website: cardiodiagnosticsinc.com
Employees: 1
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

Mana Capital Acquisition Corp. focuses on engaging in a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Dover, Delaware.

Recent news
loading